When a stock that couldn’t get arrested for most of the last year suddenly nearly doubles in a single day, you’d expect to find some sort of paper trail that would point to why.
AgraFlora Organics International (AGRA.C) gets the Home Office nod for entry into the U.K. medical cannabis market
AgraFlora Organics International’s (AGRA.C) European subsidiary Farmako GmbH has received the go-ahead from the Home Office in the U.K. for a controlled drug licence.
Way way waaaay back, when Equity.Guru was a young pup and the cannabis industry was still being built on fumes of promise, Vivo Cannabis (VIVO.V) – formerly AbCann – was an industry darling.
If Equity.Guru had a wall of shame in our fine sea foam blue offices, Namaste would be on it, along with Wayland Group (WAYL.C), CEN Biotech (FITX), MedMen (MMEN.C), St Jean Carbon (SJL.V), Imagination Park (IP.C), Affinor Growers (AFI.C), Abattis Bioceuticals (ATT.C), CUV Ventures/RevoluGroup (REVO.V), and a host of others that we went to war against at one time or another.
Naturally Splendid (NSP.V) puts off chaotic cannabis 2.0 for now to focus on nutritional bars and bites
If you’re anything like Naturally Splendid (NSP.V) then you’re not exactly enthusiastic about the cannabis 2.0 market’s chances, and you’re also fairly smart. So congrats on both of those.
Friday Roundup: Canopy Growth (WEED.T), Curaleaf Holdings (CURA.C), and Auxly Cannabis (XLY.C) prepare for cannabis 2.0
First up in cannabis 2.0 news, the Ontario Cannabis Store had a serious case of deja vu when it sold out of its new edible products approximately five hours after they went on sale online Thursday morning with all of the new products gone by 2 p.m.
Aleafia Health’s (ALEF.C) subsidiary, Emblem Cannabis, has signed a licensing agreement with Kinstate Inc, to bring Kin’s sublingual cannabis strips brand and tech to the Canadian medical and adult-use market.
When a cannabis company loses a lot of money every quarter, and has to sell real estate, cancel acquisitions, lay off staff, renegotiate existing financing to higher interest rates and offer stock to new financiers at a discount to the market price, all to stay afloat, one might expect their newsflow to show bold new moves, innovation, maybe some hard austerity decisions.
Medical Marijuana’s (MJNA.OTC) investment arm acquisition of oncology biotech company continues cancer fight
Medical Marijuana (MJNA.OTC) announced today that their investment company AXIM Biotechnologies (AXIM.OTC) has signed a binding term sheet to acquire oncology research and development company Sapphire Biotech.
New Experion (EXP.V) CEO lays out the real definition of cannabis 2.0… cost controls and common sense
Sick of hearing about how cannabis companies are 'on the cusp of something great' and 'leading the industry'? Well Experion's new CEO has gone another way: Truth.
Cannabis companies take a leaf from the baseball playbook, but sacking CEOs at Supreme (FIRE.T) and Experion (EXP.V) won’t placate the masses
The bodies of cannabis company CEOs are starting float down river. Honey, the CEOs ain't the problem. Name one weed company CEO any other company would hire... I'll wait.
1933 Industries (TGIF.C) announced that they’re ready to begin manufacturing their line of CBD wellness products, and debuted their subsidiary, Alternative Medicine Association’s, branded THC products for the first time for the California dispensary market.